Levetiracetam Micro Labs (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A in the brain, modulating the release of neurotransmitters. This action stabilizes neuronal firing and lowers hyper‑excitability, which helps prevent the spread of seizure activity across neural networks.

The appropriate dose of levetiracetam is determined by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Dosage adjustments are individualized, and patients should follow the specific instructions provided by their healthcare provider.

Safety data for levetiracetam in pregnancy and lactation are limited. Clinicians weigh potential benefits against possible risks before prescribing to pregnant or nursing women. Patients should discuss their individual situation with a healthcare professional before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as valproate. It is generally well‑tolerated, has fewer drug‑enzyme interactions, and may be preferred when patients experience side effects with other agents.

Levetiracetam Micro Labs should be stored at ambient temperature, below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Levetiracetam is taken orally, usually as tablets or oral solution, with or without food. The exact administration schedule—once, twice or three times daily—depends on the prescriber’s instructions and the patient’s therapeutic needs.

Serious risks include severe allergic reactions (rash, swelling, breathing difficulty), mood disorders such as depression or suicidal thoughts, and rare skin conditions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if any of these symptoms occur.

Levetiracetam is contraindicated in individuals with known hypersensitivity to the drug or any of its components. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications that may reduce its effectiveness.